What is LOPJLB’s current signal on IPSC?

LOPJLB’s latest quantitative signal on Century Therapeutics, Inc. (IPSC) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is IPSC in?

Century Therapeutics, Inc. (IPSC) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Century Therapeutics, Inc. (IPSC) do?

Century Therapeutics, Inc. is a biotechnology company dedicated to pioneering allogeneic cell therapies for a range of cancers, specifically solid tumors and hematological malignancies. The firm's foremost clinical program is CNTY-101, an allogeneic, induced pluripotent stem cell (iPSC)-derived CAR-iNK cell therapy. This therapy is specifically designed to target CD19 in patients with B-cell ly…